Get App Open
In App
Lending
Lending
Open App

Nippon India Nifty Pharma ETF

  • Regular
  • Direct
Category : Index Funds/ETFs
  • NAV
    : ₹ 23.3799 0.59%
    (as on 14th November, 2025)
Crisil Rating

Not Rated

Rank not available for the fund
Risk-O-Meter
Very High Risk

The fund has 99.97% investment in domestic equities of which 53.22% is in Large Cap stocks, 19.74% is in Mid Cap stocks, 2.61% in Small Cap stocks.

This Scheme
VS
  • Nifty Pharma TRI
  • NA
  • NA
  • Gold
Compare with
  • Date : -
  • NAV : -
  • Date : -
  • Investment : -
  • Value on selected date : -
  • Returns Calculator
  • SIP Calculator
  • VIP (Value Avg)
Amount
  • Investment Date
  • Sell Date
  • Investment Value
    -
  • Sell Value
    -
  • Profit/Loss
    -
  • Annualised Returns
    -
  • Date : -
  • Investment : -
  • Value on selected date : -

Returns (NAV as on 14th November, 2025)

Period Invested for ₹10000 Invested on Latest Value Absolute Returns Annualised Returns Category Avg Rank within Category
1 Week 07-Nov-25 10294.80 2.95% - 1.28% 69/745
1 Month 14-Oct-25 10354.70 3.55% - 1.91% 99/739
3 Month 14-Aug-25 10299.10 2.99% - 5.95% 476/721
6 Month 14-May-25 10663.80 6.64% - 8.01% 253/681
YTD 01-Jan-25 9779.00 -2.21% - 10.08% 540/622
1 Year 14-Nov-24 10544.10 5.44% 5.44% 12.10% 457/598
2 Year 13-Nov-23 14855.40 48.55% 21.82% 17.18% 104/471
3 Year 14-Nov-22 17792.50 77.92% 21.15% 16.61% 91/364
Since Inception 06-Jul-21 16225.00 62.25% 11.74% 12.20% 337/777

SIP Returns (NAV as on 14th November, 2025)

Period Invested for ₹1000 SIP Started on Investments Latest Value Absolute Returns Annualised Returns
1 Year 14-Nov-24 12000 12638.76 5.32 % 9.98 %
2 Year 13-Nov-23 24000 27017.13 12.57 % 11.81 %
3 Year 14-Nov-22 36000 47960.52 33.22 % 19.51 %
 

Tax Treatment

Please check with your Tax Advisor.

Portfolio (Updated on 31st Oct,2025)

Portfolio Turnover Ratio : 32.00%  |   Category average turnover ratio is 34.12%  
Fund manager updated portfolio less frequently than peers in last 1 year. (I.e. fund manager held stocks/bonds in the portfolio for longer duration than peers)
Equity Holding : 99.97% | F&O Holdings : 0.00%| Foreign Equity Holdings : 0.00%| Total : 99.97%
No of Stocks : 20 (Category Avg - 54.20) | Large Cap Investments : 53.22%| Mid Cap Investments : 19.74% | Small Cap Investments : 2.61% | Other : 24.4%

Top 10 Stocks in Portfolio

How to read this table?
Stock Invested in Sector Value(Mn) % of Total Holdings 1M Change 1Y Highest Holding 1Y Lowest Holding Quantity 1M Change in Qty
Sun Pharmaceutical Industries Ltd. Pharmaceuticals 2268.9 22.18% 0.56% 25.53% (Apr 2025) 21.62% (Sep 2025) 13.42 L -1.12 k
Divis Laboratories Ltd. Pharmaceuticals 1089.9 10.65% 1.35% 11.02% (May 2025) 9.3% (Sep 2025) 1.62 L -0.14 k
Cipla Ltd. Pharmaceuticals 1075.3 10.51% -0.37% 11.43% (Aug 2025) 10.21% (Dec 2024) 7.16 L -0.60 k
Dr. Reddys Laboratories Ltd. Pharmaceuticals 929.1 9.08% -0.51% 10.29% (Dec 2024) 9.08% (Oct 2025) 7.76 L -0.65 k
Lupin Ltd. Pharmaceuticals 604.9 5.91% -0.04% 6.9% (Dec 2024) 5.7% (Jul 2025) 3.08 L -0.26 k
Torrent Pharmaceuticals Ltd. Pharmaceuticals 474.2 4.64% -0.21% 4.85% (Sep 2025) 3.83% (Dec 2024) 1.33 L -0.11 k
Laurus Labs Ltd. Pharmaceuticals 471.8 4.61% 0.40% 4.61% (Oct 2025) 2.86% (Nov 2024) 4.95 L -0.41 k
Aurobindo Pharma Ltd. Pharmaceuticals 405.6 3.97% 0.07% 4.53% (Dec 2024) 3.68% (Aug 2025) 3.56 L -0.30 k
Alkem Laboratories Ltd. Pharmaceuticals 394.8 3.86% -0.07% 3.93% (Sep 2025) 3.31% (Jul 2025) 71.71 k -60.00
Glenmark Pharmaceuticals Ltd. Pharmaceuticals 362.7 3.55% -0.23% 3.93% (Jul 2025) 2.69% (Apr 2025) 1.92 L -0.17 k
- indicates change in weight in the portfolio. # indicates a new entry.
Name Type of Instrument Weight (%)
TREPS TREPS 0.38%
Margin Margin 0.00%
Net Receivables Net Receivables -0.35%

Risk Ratios

Ratios calculated on daily returns for last 3 years (Updated as on 31st October, 2025)

  • Standard Deviation

    High volatility
    14.42vs11.1
    Category Avg
  • Beta

    High volatility
    1vs0.86
    Category Avg
  • Sharpe Ratio

    Poor risk adjusted returns
    0.91vs0.96
    Category Avg
  • Treynor's Ratio

    Poor risk adjusted returns
    0.13vs0.59
    Category Avg
  • Jensen's Alpha

    Poor risk adjusted returns
    -0.22vs1.24
    Category Avg

Alternative Funds (Category Peers)

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
HDFC Silver ETF NA 3177.76 -9.93 38.27 64.31 81.59 34.77
ICICI Prudential Silver ETF NA 9445.03 -9.93 38.35 64.51 81.45 34.94
Aditya Birla Sun Life Silver ETF NA 1756.21 -9.92 38.25 64.40 81.40 34.97
DSP Silver ETF NA 1374.63 -9.82 38.37 64.47 81.36 35.20
Axis Silver ETF NA 720.88 -9.91 38.17 64.27 81.23 34.80
Mirae Asset Silver ETF NA 460.88 -9.87 38.26 64.33 81.21 0.00
Kotak Silver ETF NA 2305.14 -9.94 38.24 64.28 81.16 0.00
SBI Silver ETF NA 2330.68 -9.90 38.17 64.15 80.94 0.00
Nippon India Silver ETF NA 17525.28 -9.91 38.18 64.16 80.82 35.05
Edelweiss Silver ETF NA 567.57 -9.90 38.12 64.09 80.77 0.00

More Funds from Nippon India Mutual Fund

Out of 130 mutual fund schemes offered by this AMC, 1 is/are ranked 5 * , 10 is/are ranked 4 * , 15 is/are ranked 3 * , 6 is/are ranked 2 * , 3 is/are ranked 1 * , and 95 schemes are not ranked. See more about AMC

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
Nippon India Small Cap Fund - Growth 4 68969.15 1.75 2.84 6.07 1.14 22.63
Nippon India ETF Nifty 50 BeES 4 53989.02 3.19 5.37 6.04 11.42 13.46
Nippon India ETF Nifty 50 BeES 4 53989.02 3.19 5.37 6.04 11.42 13.46
Nippon India Multicap Fund - Growth 4 49313.70 1.17 2.19 7.03 7.08 21.88
Nippon India Large Cap Fund - Growth 5 48870.60 2.02 3.87 6.75 10.43 18.81
Nippon India Growth Mid Cap Fund - Growth 4 41267.69 2.31 4.05 8.21 8.87 25.33
Nippon India ETF Gold BeES NA 32605.96 -0.83 24.50 32.45 67.53 31.62
Nippon India ETF Gold BeES NA 32605.96 0.00 0.00 0.00 0.00 0.00
CPSE ETF NA 30725.34 1.01 3.17 3.83 6.35 35.18
CPSE ETF NA 30725.34 0.99 3.13 3.76 6.24 34.89
Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
Close Outskill Genai